1-15 of 15 Results

Title Investigator Disease(s)

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

[Protocol 17-1026]
Margaret von Mehren
  • Colon
  • A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

    [Protocol 19-1007]
    David Weinberg
  • Colon
  • ALKS 4230 Admin Subcutaneously w/Pembro in Subjects w/Advanced Solid Tumors

    [Protocol 18-1076]
    Anthony Olszanski
  • Colon
  • AMG510 in Subjects w/Advanced Solid Tumors with Specific KRAS Mutation

    [Protocol 18-1061]
    Crystal Denlinger
  • Colon
  • Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer

    [Protocol 18-2004]
    Juhi Mittal
  • Colon
  • Anti-TIM-3 mAB BGB-A425 w/Anti-PD-1 mAB Tislelizumab in Pts w/Solid Tumors

    [Protocol 18-1045]
    Crystal Denlinger
  • Colon
  • Crenolanib in Pts w/Metastatic Gastrointestinal Stromal Tumors w/a D842V Mutation in the PDGFRA Gene

    [Protocol 16-1063]
    Margaret von Mehren
  • Colon
  • Evaluation of ASP8374, an Immune Checkpoint Inhibitor, in Subjects with Advanced Solid Tumors

    [Protocol 17-1051]
    Anthony Olszanski
  • Colon
  • Intratumorally Administered INT230-6 in Adult Subjects with Advanced Refractory Cancers

    [Protocol 17-1022]
    Anthony Olszanski
  • Colon
  • Linaclotide in Patients with Sporadic Colorectal Adenomas and with Colorectal Cancer

    [Protocol 18-1058]
    David Weinberg
  • Colon
  • Molecular Analysis for Therapy Choice (MATCH)

    [Protocol 15-7002]
    Lori Goldstein
  • Colon
  • Mychoice: Testing an Interactive mHealth Tool to Enhance Communication and Informed Decision Making

    [Protocol 17-8013]
    Linda Fleisher
  • Colon
  • Tecentriq with Taxol, Herceptin, and Perjeta in treating Metastatic HER-2 Positive Breast Cancer

    [Protocol 17-1010]
    Lori Goldstein
  • Colon
  • Tislelizumab (BGB-A317) Vs Placebo in pts. with Gastric/Gastroesophageal Adenocarcinoma

    [Protocol 18-1070]
    Crystal Denlinger
  • Colon
  • Trastuzumab&Pertuzumab Compared to Cetuximab&Irinotecan in Adv/MCRC w/HER-2 Amplification

    [Protocol 18-2002]
    Crystal Denlinger
  • Colon